PT934075E - Metodo para a prevencao e tratamento da mastite - Google Patents

Metodo para a prevencao e tratamento da mastite

Info

Publication number
PT934075E
PT934075E PT97929226T PT97929226T PT934075E PT 934075 E PT934075 E PT 934075E PT 97929226 T PT97929226 T PT 97929226T PT 97929226 T PT97929226 T PT 97929226T PT 934075 E PT934075 E PT 934075E
Authority
PT
Portugal
Prior art keywords
micrococcin
mastitis
infection
antibiotics
prevention
Prior art date
Application number
PT97929226T
Other languages
English (en)
Inventor
Bruno Suri
John Edmondson Peel
Catherine Georges
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT934075E publication Critical patent/PT934075E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
PT97929226T 1996-06-20 1997-06-19 Metodo para a prevencao e tratamento da mastite PT934075E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20

Publications (1)

Publication Number Publication Date
PT934075E true PT934075E (pt) 2002-08-30

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97929226T PT934075E (pt) 1996-06-20 1997-06-19 Metodo para a prevencao e tratamento da mastite

Country Status (14)

Country Link
US (1) US6187800B1 (pt)
EP (1) EP0934075B1 (pt)
JP (1) JP2000513348A (pt)
CN (1) CN1119170C (pt)
AT (1) ATE215378T1 (pt)
AU (1) AU720243B2 (pt)
BR (1) BR9709812A (pt)
CA (1) CA2251779A1 (pt)
DE (1) DE69711661T2 (pt)
DK (1) DK0934075T3 (pt)
ES (1) ES2175425T3 (pt)
IL (1) IL126489A0 (pt)
PT (1) PT934075E (pt)
WO (1) WO1997048408A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
CA2440353A1 (en) * 2001-03-13 2002-09-19 Yamanouchi Pharmaceutical Co., Ltd. Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
CN1226998C (zh) * 2002-06-28 2005-11-16 陈放 可控释型奶道栓
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
EP1942902A1 (en) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN103735574A (zh) * 2006-10-10 2014-04-23 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
MX2011010603A (es) 2009-04-08 2011-12-08 Wisconsin Alumni Res Found Formulacion de sellador de pezon intra-mamario y metodo para usar la misma para reducir o eliminar defectos visuales en quesos añejados.
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
KR20150115837A (ko) * 2013-02-08 2015-10-14 루오다 파마 피티와이 리미티드 유방염을 포함하는 미생물 감염의 치료방법
CA2900372C (en) * 2013-02-08 2021-06-08 Luoda Pharma Pty Ltd Methods of treating topical microbial infections
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
US20180177692A1 (en) * 2016-12-27 2018-06-28 Colgate-Palmolive Company Antiperspirant / Deodorant Composition
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
US20240277800A1 (en) * 2021-05-21 2024-08-22 A & J Science Co., Ltd. Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710124A (en) * 1993-08-20 1998-01-20 Novartis Corporation Method for combatting bovine mastitis

Also Published As

Publication number Publication date
WO1997048408A2 (en) 1997-12-24
CN1119170C (zh) 2003-08-27
DK0934075T3 (da) 2002-06-10
CA2251779A1 (en) 1997-12-24
EP0934075A2 (en) 1999-08-11
US6187800B1 (en) 2001-02-13
EP0934075B1 (en) 2002-04-03
AU3341097A (en) 1998-01-07
BR9709812A (pt) 1999-08-10
AU720243B2 (en) 2000-05-25
CN1222081A (zh) 1999-07-07
JP2000513348A (ja) 2000-10-10
WO1997048408A3 (en) 1998-02-19
ATE215378T1 (de) 2002-04-15
ES2175425T3 (es) 2002-11-16
DE69711661D1 (de) 2002-05-08
DE69711661T2 (de) 2002-10-17
IL126489A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
PT934075E (pt) Metodo para a prevencao e tratamento da mastite
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
MY118641A (en) Method of preventing, countering or reducing chronic gastrointestinal disorders or nsaid-induced gastrointestinal damage
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
SE9901647L (sv) Anordning för behandling av spenar
AU6289196A (en) A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
Nagahata et al. Effects of intramammary infusion of Bifidobacterium breve on mastitis pathogens and somatic cell response in quarters from dairy cows with chronic subclinical mastitis
ATE223649T1 (de) Mittel zum eintauchen von zitzen
EP0301785A3 (en) Carboxamide derivatives of glycopeptides
GR3036573T3 (en) Method for the prevention and treatment of bovine mastitis
Hogan et al. Efficacy of dry cow therapy and a Propionibacterium acnes product in herds with low somatic cell count
NZ790211A (en) Compositions and methods of use thereof for treatment of mastitis
Janosi et al. The use of the dry cow therapy in the control of bovine mastitis
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
WO2004071324A3 (en) Method to reduce, eliminate, or prevent bacterial pathogen colonization in eggs and/or poultry using bacteriophages
NZ503145A (en) 8a-Azalides as veterinary antimicrobial agents to treat bacterial respiratory infection
US7045510B2 (en) Methods for prevention and treatment of mastitis
Hogan et al. Efficacy of parenteral vitamin E for treating bovine mastitis.
WO2022220699A3 (en) A bacteriophage preparation in the form of gel to prevent or treat bacterial infections in dairy cattle, its manufacturing method and bacteriophage strains
DE60222298D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
Žilaitis et al. Effect of low intensity laser radiation on cow’s milk microflora and somatic cell count
Yuliza Purba et al. Effect of temporary cessation of milking on the innate immune components in goat milk
CA3297227A1 (en) Autonomous system and methods thereof for treatment and injection of medicaments, beneficial agents and the like in livestock and wild animals
AU2024296443A1 (en) Autonomous system and methods thereof for treatment and injection of medicaments, beneficial agents and the like in livestock and wild animals
WO2024192151A3 (en) Method of dosing vapendavir to treat enterovirus infections